Jessica Gautreaux
Neurology with Special Qualifications in Child Neurology · New Orleans, LANPI 1760666556
Payments from drug & device makers
What this record shows
34 manufacturers reported payments, led by Pfizer at 59.5% of the total. 2025 is the largest year on record at $5,487, 6.7 times the $818 reported in 2019.
Across 168 payments — averaging $50.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$5K
- UCB, Inc.$445
- Supernus Pharmaceuticals, Inc.$418
- Eisai Inc.$399
- Neurelis, Inc.$253
- Immedica Pharma US, Inc.$157
- plus $2K from 28 others
Across 20 payments — averaging $10,520 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$210K
What the payments were for
- Consulting fees$5,00059%
- Food & beverage$3,53341%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 4 | $5,076 |
| UCB, Inc. | 17 | $445 |
| Supernus Pharmaceuticals, Inc. | 37 | $418 |
| Eisai Inc. | 20 | $399 |
| Neurelis, Inc. | 8 | $253 |
| Immedica Pharma US, Inc. | 6 | $157 |
| AstraZeneca | 2 | $143 |
| Jazz Pharmaceuticals Inc. | 6 | $132 |
| Sarepta Therapeutics, Inc. | 5 | $129 |
| Genentech USA, Inc. | 6 | $125 |
| Sunovion Pharmaceuticals Inc. | 9 | $124 |
| Novartis | 6 | $110 |
| Biogen | 4 | $89 |
| Catalyst Pharmaceuticals, Inc. | 3 | $87 |
| SK Life Science, Inc. | 3 | $73 |
| Zevra Therapeutics Inc | 1 | $72 |
| Lilly USA, LLC | 3 | $72 |
| ITF Therapeutics LLC | 2 | $61 |
| Biocodex, Inc. | 1 | $55 |
| Upsher-smith Laboratories LLC | 2 | $55 |
| NS Pharma, Inc. | 3 | $52 |
| PTC Therapeutics, Inc. | 2 | $48 |
| Biomarin Pharmaceutical Inc. | 3 | $46 |
| Aucta Pharmaceuticals, Inc. | 2 | $43 |
| Sanofi | 2 | $43 |
| Greenwich Biosciences, Inc. | 2 | $42 |
| Mallinckrodt Enterprises LLC | 1 | $28 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 1 | $27 |
| Amneal Pharmaceuticals LLC | 2 | $27 |
| Boston Scientific | 1 | $25 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $22 |
| Impel Pharmaceuticals Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Metacel Pharmaceuticals LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$4,375
How this compares
$8,533 in reported general payments places this provider in the 60th percentile of 30 neurology with special qualifications in child neurology providers in Louisiana.
See all neurology with special qualifications in child neurology providers in Louisiana →
Other neurology with special qualifications in child neurology in New Orleans
- Ann Henderson TiltonNew Orleans$119K
- Joaquin WongNew Orleans$28K
- Allison ConraveyNew Orleans$15K
- David HoughtonNew Orleans$9K
- Jeremy TolerNew Orleans$9K
- Daniella MillerNew Orleans$8K
- Maria WeimerNew Orleans$6K
- Rashmi RaoNew Orleans$5K
- Kelly AngelleNew Orleans$3K
- Kayla PenceNew Orleans$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.